Company Profile

Company Description

CytoDyn Inc. is a biotechnology firm focused on developing innovative therapies for life-threatening diseases. Its flagship product, leronlimab, is a monoclonal antibody targeting HIV, cancer, and autoimmune conditions. The company emphasizes research in immunology and infectious diseases, aiming to address unmet medical needs. Despite facing regulatory challenges, it continues to explore potential treatments through clinical trials and partnerships. Investors closely monitor its progress due to its high-risk, high-reward pipeline in the competitive biotech sector.